189 related articles for article (PubMed ID: 32104719)
1. Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy.
Schulte B; Wübbolding M; Marra F; Port K; Manns MP; Back D; Cornberg M; Stichtenoth DO; Höner Zu Siederdissen C; Maasoumy B
Open Forum Infect Dis; 2020 Feb; 7(2):ofaa040. PubMed ID: 32104719
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents.
Murray M
Clin Pharmacokinet; 2023 Oct; 62(10):1365-1392. PubMed ID: 37731164
[TBL] [Abstract][Full Text] [Related]
3. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
[TBL] [Abstract][Full Text] [Related]
4. Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.
Hsu PY; Wei YJ; Lee JJ; Niu SW; Huang JC; Hsu CT; Jang TY; Yeh ML; Huang CI; Liang PC; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Hwang SJ; Chuang WL; Huang CF; Chiu YW; Yu ML
Clin Mol Hepatol; 2021 Jan; 27(1):186-196. PubMed ID: 33317251
[TBL] [Abstract][Full Text] [Related]
5. Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.
Höner Zu Siederdissen C; Maasoumy B; Marra F; Deterding K; Port K; Manns MP; Cornberg M; Back D; Wedemeyer H
Clin Infect Dis; 2016 Mar; 62(5):561-7. PubMed ID: 26611779
[TBL] [Abstract][Full Text] [Related]
6. Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis C.
Kuo MH; Tseng CW; Lee CH; Tseng KC
Tzu Chi Med J; 2020; 32(4):331-338. PubMed ID: 33163377
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a specialty hepatitis C virus telephone pharmacy service.
Sabourin AA; Fisher-Grant KK; Saulles AR; Mohammad RA
Am J Health Syst Pharm; 2021 May; 78(Supplement_2):S38-S45. PubMed ID: 33684928
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project.
Borghi C; Ciancio A; Gentile I; Perrone Filardi P; Pasqualetti P; Brillanti S
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498521
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Drug Interactions Identified by Clinical Pharmacists in Veterans Initiating Treatment for Chronic Hepatitis C Infection.
Ottman AA; Townsend ML; Hashem MG; DiMondi VP; Britt RB
Ann Pharmacother; 2018 Aug; 52(8):763-768. PubMed ID: 29577765
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.
Maasoumy B; Port K; Calle Serrano B; Markova AA; Sollik L; Manns MP; Cornberg M; Wedemeyer H
Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1365-72. PubMed ID: 24127648
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Risk Management and Hepatitis C: Combining Drugs.
Smolders EJ; Ter Horst PJG; Wolters S; Burger DM
Clin Pharmacokinet; 2019 May; 58(5):565-592. PubMed ID: 30259390
[TBL] [Abstract][Full Text] [Related]
12. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
Rodríguez-Torres M
Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
[TBL] [Abstract][Full Text] [Related]
13. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
Kondili LA; Gaeta GB; Ieluzzi D; Zignego AL; Monti M; Gori A; Soria A; Raimondo G; Filomia R; Di Leo A; Iannone A; Massari M; Corsini R; Gulminetti R; Gatti Comini A; Toniutto P; Dissegna D; Russo FP; Zanetto A; Rumi MG; Brancaccio G; Danieli E; Brunetto MR; Weimer LE; Quaranta MG; Vella S; Puoti M
PLoS One; 2017; 12(2):e0172159. PubMed ID: 28245248
[TBL] [Abstract][Full Text] [Related]
14. Drug-Drug Interactions Potential of Direct-Acting Antivirals for the treatment of Chronic Hepatitis C Virus infection.
Néant N; Solas C
Int J Antimicrob Agents; 2020 Jul; 56(1):105571. PubMed ID: 30394302
[TBL] [Abstract][Full Text] [Related]
15. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
[TBL] [Abstract][Full Text] [Related]
16. Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications.
Smolders EJ; de Kanter CT; de Knegt RJ; van der Valk M; Drenth JP; Burger DM
Clin Pharmacokinet; 2016 Dec; 55(12):1471-1494. PubMed ID: 27317413
[TBL] [Abstract][Full Text] [Related]
17. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
Seden K; Back D
Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
[TBL] [Abstract][Full Text] [Related]
18. High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
Macías J; Monge P; Mancebo M; Merchante N; Neukam K; Real LM; Pineda JA
HIV Med; 2017 Aug; 18(7):445-451. PubMed ID: 27882706
[TBL] [Abstract][Full Text] [Related]
19. Prioritization for interferon-free regimens and potential drug interactions of current direct-acting anti-hepatitis C agents in routine clinical practice.
Papatheodoridi Μ; Dalekos GN; Goulis J; Manolakopoulos S; Triantos C; Zachou K; Koukoufiki A; Κourikou Α; Ζisimopoulos Κ; Τsoulas C; Papatheodoridis GV
Ann Gastroenterol; 2017; 30(5):542-549. PubMed ID: 28845110
[TBL] [Abstract][Full Text] [Related]
20. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.
Jiang X; Vouri SM; Diaby V; Lo-Ciganic W; Parker R; Park H
J Manag Care Spec Pharm; 2021 Oct; 27(10):1388-1402. PubMed ID: 34595949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
